Literature DB >> 3040542

Vagal cholinergic control of gastric alkaline secretion in normal subjects and duodenal ulcer patients.

S J Konturek, N Kwiecień, W Obtułowicz, P Thor, J W Konturek, T Popiela, J Oleksy.   

Abstract

Gastric alkaline secretion was determined in ranitidine treated healthy subjects and duodenal ulcer (DU) patients using gastric perfusion aspiration system and back titration of gastric perfusate to original pH 6.0. Basal alkaline secretion showed periodic fluctuations reaching peaks at phase III of the migrating motor complex (MMC) in the stomach. Mean basal alkaline secretion in healthy normals and DU patients averaged 1120 +/- 124 and 880 +/- 72 mumol/h, respectively and no correlation was found between basal and maximally stimulated gastric acid and alkaline secretion. Modified sham feeding in normal subjects and in DU patients increased this secretion to the peaks of about 28 and 36% of the maximal alkaline response to intragastric application of 16,16 dimethyl-PGE2 in these subjects. Vagotomy did not affect significantly basal alkaline secretion but prevented the rise in alkaline secretion induced by modified sham feeding. Atropine (5-20 micrograms/kg) decreased dose dependently basal, and prevented the modified sham feeding induced alkaline secretion, while pirenzepine (5-20 micrograms/kg) had little influence on basal, and did not affect the modified sham feeding induced, alkaline secretion. This study shows that basal gastric alkaline secretion fluctuates in phase with gastric motor activity, and is similar in normal and DU patients. Vagal stimulation strongly increases alkaline secretion, the effect being abolished by vagotomy and atropine, but not by pirenzepine, suggesting the involvement of M2 rather than M1 subtypes of muscarinic receptors in this stimulation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3040542      PMCID: PMC1433025          DOI: 10.1136/gut.28.6.739

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  16 in total

1.  The secretory component of the interdigestive migrating motor complex in man.

Authors:  G R Vantrappen; T L Peeters; J Janssens
Journal:  Scand J Gastroenterol       Date:  1979       Impact factor: 2.423

2.  Analysis of basal acid secretion and its relation to the insulin response in normal and duodenal ulcer subjects. New criterion for the insulin test.

Authors:  G Gillespie; J B Elder; I S Smith; F Kennedy; I E Gillespie; A W Kay; E H Campbell
Journal:  Gastroenterology       Date:  1972-05       Impact factor: 22.682

3.  Effect of glucagon on meal-induced gastric secretion in man.

Authors:  S J Konturek; J Biernat; N Kwiecień; J Oleksy
Journal:  Gastroenterology       Date:  1975-03       Impact factor: 22.682

4.  The interdigestive motor complex of normal subjects and patients with bacterial overgrowth of the small intestine.

Authors:  G Vantrappen; J Janssens; J Hellemans; Y Ghoos
Journal:  J Clin Invest       Date:  1977-06       Impact factor: 14.808

Review 5.  Gastroduodenal defence mechanisms.

Authors:  G Flemström; L A Turnberg
Journal:  Clin Gastroenterol       Date:  1984-05

Review 6.  Antacids and anticholinergics in the treatment of duodenal ulcer.

Authors:  A Walan
Journal:  Clin Gastroenterol       Date:  1984-05

7.  Prostaglandins and alkaline secretion from oxyntic, antral, and duodenal mucosa of the dog.

Authors:  S J Konturek; J Tasler; J Bilski; J Kania
Journal:  Am J Physiol       Date:  1983-10

8.  Gastric bicarbonate secretion in humans. Effect of pentagastrin, bethanechol, and 11,16,16-trimethyl prostaglandin E2.

Authors:  M Feldman
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

9.  Cephalic phase of gastric secretion in healthy subjects and duodenal ulcer patients: role of vagal innervation.

Authors:  S J Konturek; N Kwiecien; W Obtulowicz; E Mikos; E Sito; J Oleksy; T Popiela
Journal:  Gut       Date:  1979-10       Impact factor: 23.059

Review 10.  Gastroduodenal HCO3(-) transport: characteristics and proposed role in acidity regulation and mucosal protection.

Authors:  G Flemstrom; A Garner
Journal:  Am J Physiol       Date:  1982-03
View more
  7 in total

1.  Netazepide, a gastrin/CCK2 receptor antagonist, causes dose-dependent, persistent inhibition of the responses to pentagastrin in healthy subjects.

Authors:  Malcolm Boyce; Steve Warrington; James Black
Journal:  Br J Clin Pharmacol       Date:  2013-11       Impact factor: 4.335

2.  Changes in gastric alkaline secretion by ulcer healing drugs.

Authors:  M Guslandi
Journal:  Gut       Date:  1988-05       Impact factor: 23.059

3.  Duodenal mucosal bicarbonate secretion in man. Stimulation by acid and inhibition by the alpha 2-adrenoceptor agonist clonidine.

Authors:  L Knutson; G Flemström
Journal:  Gut       Date:  1989-12       Impact factor: 23.059

4.  Neural influences on human esophageal and salivary alkali secretion.

Authors:  C M Brown; C F Snowdon; B Slee; L N Sandle; W D Rees
Journal:  Dig Dis Sci       Date:  1995-08       Impact factor: 3.199

5.  De-Nol stimulates gastric and duodenal alkaline secretion through prostaglandin dependent mechanism.

Authors:  S J Konturek; J Bilski; N Kwiecien; W Obtuløwicz; B Kopp; J Oleksy
Journal:  Gut       Date:  1987-12       Impact factor: 23.059

6.  CCK receptor antagonism by loxiglumide and gall bladder contractions in response to cholecystokinin, sham feeding and ordinary feeding in man.

Authors:  J W Konturek; S J Konturek; A Kurek; J Bogdal; J Oleksy; L Rovati
Journal:  Gut       Date:  1989-08       Impact factor: 23.059

7.  Muscarinic M1 receptor inhibition reduces gastroduodenal bicarbonate secretion and promotes gastric prostaglandin E2 synthesis in healthy volunteers.

Authors:  A Mertz-Nielsen; J Hillingsø; O Eskerod; K Bukhave; J Rask-Madsen
Journal:  Gut       Date:  1995-04       Impact factor: 23.059

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.